Could proteolytic enzyme modulate the interaction platelets/vessel wall in presence of ASA at ultra low doses?

Thromb Res. 1991 Aug 15;63(4):419-26. doi: 10.1016/0049-3848(91)90228-o.

Abstract

Acetylsalicylic acid (ASA) is known to act on platelets and vessel walls. At ultra low doses it reverses the inhibitory effects produced by a vascular fragment. Use of papain on normal platelets in vitro led to the appearance of platelet aggregation without collagen induction with a range of 20.25 +/- 28.91%. In the presence of vascular fragments (without ASA), this "spontaneous" aggregation remained but was reduced (13.26 +/- 27.73%). This effect was reversed by ASA treatment (29.41 +/- 24.17%). Reversion of vascular inhibition by ASA was not modified by papain.

MeSH terms

  • Aspirin / administration & dosage*
  • Aspirin / pharmacology
  • Blood Platelets / drug effects*
  • Blood Vessels / drug effects*
  • Dose-Response Relationship, Drug
  • Humans
  • In Vitro Techniques
  • Papain / physiology*
  • Platelet Aggregation / drug effects
  • Solutions

Substances

  • Solutions
  • Papain
  • Aspirin